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 The research aimed to determine the pattern of changes in serum levels of 
NT-3 in the improvement of diabetic neuropathy, after doing diabetic foot 
exercise. A true experimental study with randomaized pre – post test control 
trial. A total of 36 subjects meeting the inclusion and exclusion criteria were 
included in the exercise group or the control one with age matched 
systematic random sampling method. Exercise group had a significant 
improvement on the score of ABI (p.0.002), systolic blood pressure 
(p.0.014), diastolic blood pressure (p.0.055), DNS (p.0.01), DNE (p.0.001) 
and increased of serum level of NT-3 (p.0.049). Control group had result 
respectively on ABI (p.0.131), systolic blood pressure (p.0.668), diastolic 
blood pressure (p.0.216), DNS (p.1.00), DNE (p.0.543), and increase of NT-
3 (p.0.264). The comparation results of the two groups had a significant 
different on the score of ABI (p.0.01), systolic blood pressure (p.0.01), 
diastolic blood pressure (p.0.01), DNS (p.0.01), DNE (p.0.01), and increased 
of NT-3 (p.0.01). Diabetic foot exercise had a peripheral affect on a clinically 
significant improvement based on ABI scores, systolic and diastolic blood 
pressure, DNS and DNE, and increase of serum level of NT-3. 
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1. INTRODUCTION 
Diabetes mellitus (DM) is one of the major problems for human health in the 21st century. The 
World Health Organization (WHO) predicts the more increasing number of people with diabetes in various 
countries including Indonesia [1]-[3]. 
Since the discovery of insulin, diabetes complications have shifted from acute to chronic 
complications namely macroangiopathy, microangiopathy and diabetic neuropathy. Diabetic neuropathy is a 
group of progressive degenerative diseases involving the peripheral nervous system due to DM. Its 
prevalence ranges from 20% - 62% among various countries. In Indonesia, the data and information centers 
of the Basic Health Research during 2011 informed that diabetic neuropathy affects more than 50% of 
diabetic patients with amputation numbers ranging from 15-30%. In Cipto mangunkusumo Hospital Jakarta 
(West Java – Indonesia), in 2007, this amputation figures reached 35% with an increase of 54% by 2011. In 
Surabaya (East Java – Indonesia), 51% patients with diabetes experienced peripheral neuropathy who were 
found in the outpatient department of polyclinic for diabetes of Dr. Soetomo General Hospital Surabaya. 
Moreover, in the inpatient department of internal medicine division, it was noted that 90.03% of neuropathy 
in diabetes patients was with complications of diabetic foot. These great problems led to a high number of 
disabilities, declining productivity and huge costs [1]-[3].  
Efforts in preventing the disease have been conducted. Indonesian Society of Endocrinology 
(PERKENI) in 2011 Consensus Management and Prevention of Diabetes Mellitus Type 2 in Indonesia had 
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set four main pillars in managing diabetes, namely: education, diet, pharmacology and exercise. DM experts 
have invented the exercise procedures though not all of the types were recommended for people with diabetes 
since DM is a chronic disease with various patients’ conditions from mild to severe. Those patients with 
complications need to adjust the intensity. Slower rhythms and movements have been created known as 
diabetic foot exercise [4]. 
Various clinical benefits from the exercise for DM patients have been reported as well as those of 
laboratory, especially the role of growth factor. Nerve growth factor is called neurotrophin, including 
neurotrophin-3 (NT-3). NT-3 contributes in the prevention of degenerative neurons. NT-3 is unique among 
neurotrophins in terms of number and potential to stimulate, referring to its ability to activate multiple 
tyrosine kinase neurotrophin receptor (eg, TrkC and TrkB). All neurotrophins are in muscles, but the majority 
of afferent muscles (75%) expresses TrkC and is responsive to NT-3. Muscle contractions in diabetic foot 
gymnastics will trigger the translocation of GLUT4 so that the transport of glucose into cells increases. This 
can be employed as energy and reduction of hyperglycemia. Foot exercise also improve blood circulation [5]-
[10]. 
Several studies have been performed on the exercise with high and mild intensity associated with 
neurotrophin, but not the ones with mild stretching exercises like foot exercise related with NT-3, added with 
the unclear patterns of changes in NT-3 levels. If the pattern can be explained scientifically, the management 
of diabetes mellitus with diabetic foot gymnastics is accountable [11]-[22]. 
Accordingly, this study is designed to determine the pattern of changes in serum levels of NT-3 in 
the improvement of diabetic neuropathy, after doing diabetic foot exercise. 
 
 
2. RESEARCH METHOD  
This study is a true experimental one with randomized pre-test post-test control group design 
method. A total of 36 subjects meeting the inclusion and exclusion criteria were included in the treatment 
group (18 subjects) or the control one (18 subjects) with age matched systematic random sampling method. 
Measuring variables was performed before and after the treatment of performing diabetic foot gymnastics for 
4 weeks with once-daily dosing. The control group did not perform diabetic foot exercise, but their daily 
physical activity as usual. Inclusion criteria for this study were: (1) patients with diabetic neuropathy of mild, 
moderate, or severe level both men and women, (2) aged 40-64 years old, (3) not suffering from a disease 
affecting the lower extremity and interfering exercise performance, (4) not possessing impaired renal 
function by examining the levels of uric acid, urea and creatinine, (5) not having mental illness, malignancy, 
impaired cognition and communication disorders, (6) willing to be a sample by signing informed consent. In 
addition, exclusion criterion was alcohol consumption.  
Foot exercise can improve blood circulation which will be assessed by an ankle brachial index 
(ABI), systolic and diastolic blood pressure scoring. This blood circulation and energy transport 
improvement will also improve cell function. This will be a biomolecular assessment through the 
measurement of serum protein levels potential for improving diabetic neuropathy is NT-3. The patterns of 
changes in levels of NT-3 will be analyzed. Clinically, improved diabetic neuropathy will be assessed 
through the signs and symptoms of diabetic neuropathy scale (DNS) and diabetic neuropathy examination 
(DNE). The other controlled variables are age, sex, HbA1c, BMI, DM and hypertension duration, renal 
function and lipid profile.  
Variables in this research include the independent, dependent and controlled ones. The independent 
includes diabetic foot exercise, the activity of performing diabetic foot exercise with the procedures as 
specified by PERKENI, while the dependent ones are ABI scores, systolic and diastolic blood pressure, DNS, 
DNE, serum levels of NT-3. In addition to the controlled, namely the degree of diabetic neuropathy based on 
ENMG examination, diabetic patients with status of HbA1c levels, lipid profile of total cholesterol level, 
HDL, LDL and triglyceride, renal function of uric acid, urea, and creatinine levels, DM and hypertension 
duration, BMI, age, and sex.  
Serum levels of NT-3 were examined with reagents of Human NT-3 Elisa kit of RayBiotech, Inc. 
products, Norcross, GA 30092, USA, Cat: ELH-NT-3, Lot: 523 140 177. Diagnosis of diabetic neuropathy is 
confirmed with electroneuromyography (ENMG) examination. 
The study was conducted in the clinic of internal medicine and neurological of General Hospital at 
PKU Muhammadiyah, Yogyakarta - Indonesia. The protocol for the research has been approved by the ethics 
committee of the Faculty of Medicine, Gajah Mada University, and conducted in accordance with the 
declaration of Helsinki. Data analysis was performed using SPSS 21, the level of significance was set at p 
<0.05. 
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3. RESULTS AND ANALYSIS  
Preliminary data found, the subjects in both groups suffered from no significant differences of mild, 
moderate and severe neuropathy (p 0.370) is shown in Table 1.  
 
 
Table 1. Basic characteristic - Level of Neuropathy diabetic 
Neuropathy 
Diabetic 
Exercise Group Control Group  
Total 
 
p* n % n % 
Mild 1 5.6% 3 16.7% 4 
0.370 
Moderate 6 33.3% 3 16.7% 9 
Severe 11 61.1% 12 66.7% 23 
Total 18 100% 18 100% 36 
* = Fisher’s exact test 
 
 
There was no significant difference in the examination of renal function in the levels of uric acid (p 
0.619) and creatinine (p 0.652). Urea levels showed a significant difference (p 0.006) but still it is within the 
range of normal limits (Table 2).  
 
 
Table 2. Basic Characteristic – Renal function 
Variable Exercise Group Control Group p* Mean +  SD Mean +  SD 
Uric acid (mg/dl) 5.405 + 1.235 5.277 + 1.059 0.619 
Ureum (mg/dl) 23.388 + 6.308 21.988 + 5.882 0.006 
Creatinine (mg/dl) 0.841 + 0.140 0.826 + 0.167 0.652 
    * = Fisher’s exact test 
 
 
Age subjects were matched so that the value of p=1. Other characteristics also showed unsignificant 
difference: gender (p 0.443), marital status (p 0.338), education (p 0.309), occupation (p 0.194), the type of 
diabetes therapy (p 0.084), BMI (p 0.545). There was a significant different in DM control status in both 
groups, HbA1c level (p 0.019) (Table 3). 
 
 
Table 3. Basic characteristic - categorical data 
Variable 
 
Exercise Group 
n= 
Control Group 
n= 
Total 
n= p* 
Age : 40-48 yo 
48-56 yo 
56-64 yo 
Total 
2 
7 
9 
2 
7 
9 
4 
14 
18 1.000 
18 18 36 
Sex : Male 
Female 
Total 
3 
15 
6 
12 
9 
27 0.443 
18 18 36 
Marital Status : Unmerried 
Married 
Widow(er) 
Total 
0 
14 
4 
1 
16 
1 
1 
30 
5 0.338 
18 18 36 
Education : Elementary 
High school 
College 
Total 
3 
9 
6 
1 
6 
11 
4 
15 
17 0.309 
18 18 36 
Occupation : entrepreneur 
employee 
ousewife/pension 
Total 
2 
8 
8 
7 
6 
5 
9 
14 
13 0.194 
18 18 36 
HbA1c : Good = < 6.5% 
Fairly = 6.5-7.0% 
Poorly = > 7.0% 
Total 
6 
1 
11 
0 
1 
17 
6 
2 
28 0.019 
18 18 36 
Therapy : Oral Anti Diabetic 
Oral Anti Diabetic + Insulin 
No therapy 
Total 
8 
5 
5 
10 
8 
0 
18 
13 
5 0.084 
18 18 36 
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BMI : Normal = 18,5-22,9 
With Risk=23,0-24,9 
Obese I = 25,0-29,9 
Obese II > 30 
Total 
6 
3 
8 
1 
10 
1 
5 
2 
16 
4 
13 
3 
0.545 
18 18 36 
* = Fisher’s exact test 
 
 
The difference was significant in urea and HbA1c levels for both groups. It will be analyzed further 
by classifying them as co-variant in the statistical analysis. 
The other variables of basic characteristic are ABI (p 0.056), systolic blood pressure (p 0.772), 
diastolic blood pressure (p 0.506), DNS (p 0.387), DNE (p 0.761), serum levels of NT-3 (p 0.676), duration 
of diabetes mellitus (p 0.266), duration of hypertension (p 0.680), cholesterol (p 0.735), HDL (p 0.665), LDL 
(p 0.479) and triglyceride (p 0.725), respectively (Table 4). 
 
 
Table 4. Basic Characteristic - Ratio Data 
Variabel 
Exercise Group 
n = 18 
Control Group 
n = 18 p* 
Mean + SD Mean + SD 
ABI 0.919 + 0.068 0.886 + 0.048 0.056 
Systolic (mmHg) 132.220 + 18.568 131.670 + 13.827 0.772 
Diastolic (mmHg) 81.110 + 8.324 80.830 + 5.491 0.506 
DNS 2.110 + 1.023 2.170 + 0.985 0.387 
DNE 3.220 +  2.211 4.280 + 2.697 0.761 
NT-3 (pg/mL) 2.850 + 0.731 1.199 + 0.493 0.676 
Duration of DM (yrs) 7.330 + 4.777 8.170 + 4.962 0.266 
Duration of hypertension (yrs) 2.500 + 0.371 3.610 + 0.722 0.680 
Cholesterol (mg/dl) 198.222 +  39.478 206.777 + 58.567 0.735 
HDL (mg/dl) 51.972 + 10.692 46.677 + 13.621 0.665 
LDL (mg/dl) 142.444 + 29.876 137.333 + 52.926 0.479 
Triglyceride (mg/dl) 143.111 + 77.398 153.388 + 47.241 0.725 
     * = Fisher’s exact test 
 
 
At the end of the study, the analysis was conducted on 15 subjects in exercise group, because 3 
subjects (16.6%) dropped out, as one subject experienced an osteoarthritis genu and two other subjects with 
myalgia (Table 5). 
 
 
Table 5. Comparation result between two group 
 
Variable 
Exercise Group n = 15 Control Group n = 17  
p*** 
(C) 
Begin End p** 
(A) 
Begin End p** 
(B) Mean +  SD Mean +  SD Mean +  SD Mean +  SD 
ABI 0.92 +  0.06 1.01 + 0.08 0.002 0.88 + 0.04 0.88 + 0.05 0.131 0.01 
Systolic 132.00 + 20.33 124.00 + 14.04 0.014 131.76 + 14.24 132.35 + 11.47 0.668 0.01 
Diastolic 82.00 + 8.61 78.67 + 9.90 0.055 80.88 + 5.65 82.06 + 5.32 0.216 0.01 
DNS 2.13 + 1.06 1.07 + 0.96 0.001 2.18 + 1.01 2.18 + 1.01 1.000 0.01 
DNE 3.20 + 2.14 1.73 + 1.66 0.001 4.41 + 2.71 4.53 + 3.01 0.543 0.01 
NT-3 1.05 + 0.23 1.26 + 0.38 0.049 1.19 + 0.50 1.98 + 1.81 0.264 0.01 
**  = Paired t test 
***  = General linear model 
 
 
The study found a significant increase in the exercise group, ABI scores were compared to the 
control group, from (0.92 + 0.06) into (1.01 + 0.08) p 0.002 vs. (0.88 + 0.04) into (0.88 + 0.05) p 0.131, 
respectively. This means there were significant differences found in the two groups with the value of p 0.01. 
It occurred in response to muscle contraction of endothelium-dependent vasodilatation or acetylcholine. 
Muscle contraction in foot gymnastics triggered neurotransmitter of acetylcholine together with the M3 
muscarinic receptor that also triggered endothelial derived vasodilator prostanoid, and then diffused into 
muscles causing vasorelaxation and a decrease in peripheral resistance [12],[13],[18]. 
Systolic blood pressure in exercise group decreased significantly, from (132.00 + 20.33) into 
(124.00 + 14.04) p 0.014 vs (131.76 + 14.24) into (132.35 + 11.47) p 0.668, respectively. Therefore, the two 
groups had significant differences with p value of 0.01. Diastolic blood pressure also decreased though not 
significant in exercise group at (82.00 + 8.61) into (78.67 + 9.90) p 0.055, whereas the control group was 
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observed with no significant increase from (80.88 + 5.65) into (82.06 + 5.32) p 0.216. Results in each of 
these groups were not significant, yet they were significant (p 0.01) when compared between the two groups 
due to the p-value of 0.055 for the exercise group. Hence, this was closer to the significance if the degree of 
significance was p <0.05, while in the control group, p-value was farther of p 0.216. Improvements in blood 
pressure occurred with regard to the onset of vasorelaxation and a decrease in peripheral resistance. Overall, 
this affected blood circulation and pressure improvements [12],[13],[18]. 
For DNS scores, the results revealed a significant improvement in exercise group, from (2.13 + 
1.06) into (1.07 + 0.96) p 0.01 and in the control group from (2.18 + 1.01) into (2.18 + 1.01) p 1.00, 
respectively. Both groups showed significant different results with p 0.01. A significant improvement of 
DNE values also occurred in the exercise group with a decline, from (3.20 + 2.14) into (1.73 + 1.66) p 0.001, 
in the control group from (4.41 + 2.71) into (4.53 + 3.01) p 0.543, consecutively. Both groups revealed 
significant different results with p 0.01. Such improvements were due to muscle contraction in diabetic foot 
gymnastics causing increased calcium ions, then activated the adenylate cyclase enzyme, hence, the ATP was 
changed into cAMP. Furthermore, cAMP helped the metabolism process and absorption of extracellular 
glucose by intra GLUT4 vesicles translocation to move near the membrane surface to transport the 
extracellular glucose to the cell to be used as energy and to reduce hyperglycemia. Increased cAMP activated 
cAMP response element-binding protein (CREB) assisting merging damaged fragments of axons and myelin 
of diabetic neuropathy. Improved blood circulation improved the supply of materials needed for regenerating 
and repairing axons and myelin. Such mechanism would repair perceptible cell function with improvement of 
DNS and DNE [23]-[25]. 
The NT-3 level was examined and discovered a significant improvement at its level, namely, in 
exercise group from (1.05 + 0.23) into (1.26 + 0.38) p 0.049, whereas in the control group from (1.19 + 0.50) 
into (1.98 + 1.81) p 0264, respectively. Differences were significant with a p-value of 0.01. These results are 
in accordance with previous data, claiming that the majority (75%) of afferent muscle expresses TrkC and is 
responsive to NT - 3. Foot exercise are more a local work in peripheral through manipulating lower limb 
muscles, thus, more local impact generates. Neurotrophin levels repair through foot exercise, relying on local 
factors, can be made possible by the mechanism of the available literature. The data show, that the glucose 
transporter (GLUT), especially GLUT-4 is the major insulin-responsive glucose transporter, located 
especially in cell muscle and adipose. In the absence of insulin, about 90 percent GLUT-4 is intracellularly 
located. Contraction of muscles in the foot exercise can stimulate GLUT-4 translocation to the plasma 
membrane and enhance glucose transport in skeletal muscle through different pathways from insulin (insulin 
independent). It allows a person with diabetes to enter muscles with energy by local stimulation i.e. leg 
muscle contraction in foot exercise. In order to build neurotrophin proteins in regenerative function the 
energy available is employed [23]-[29]. 
 
 
4. CONCLUSION 
Thus, it can be concluded that in patients with diabetic neuropathy, diabetic foot exercise has a 
peripheral effect on a clinically significant improvement based on ABI scores, systolic and diastolic blood 
pressure, DNS and DNE. A significant increase in serum levels of NT-3.   
Accordingly, the study suggests (1) clinicians to include appropriate physical exercise suitable for 
the patients’ condition. Low impact workout such as diabetic foot exercise can still be applied, especially in 
patients with severe conditions. (2) nurses, gymnastics groups, health counselors, and various stakeholders in 
health care systems to always manage to implement physical exercise including diabetic foot gymnastics in 
any effort to improve health status. (3) patients and societies to perform actively even the low impact exercise 
like diabetic foot gymnastics as proven to provide benefits. (4) further research to be done with varied dose 
and duration for the observation, subjects selection with homogeneous HbA1c, observation on constrains or 
triggering adherence factors to workout regularly, (5) therapeutic strategies in the future to consider 
neurotrophic factors particularly NT-3 level given as the least affected by diabetic foot exercise, for instance, 
an intra-muscular injection for synthetic NT-3 or an ointment.  
This study findings has several limitations: (1) no assessment on neurotrophin levels of skeletal 
muscles in the feet, (2) no biopsy as a definitive diagnosis of the onset of degeneration and regeneration, (3) 
the subjects of the study have inequivalent HbA1c levels between two groups, (4) subjects of this research 
were not grouped according to the basic status of severity in diabetic neuropathy. 
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